- Immutep Announces Positive Preliminary Topline Results from TACTI-003 Cohort B
- Immutep Reports Promising Clinical Data from INSIGHT-003 Trial at ESMO Congress 2023
- Immutep’s Efti in Combination with KEYTRUDA® Generates Excellent Overall Survival Benefit in Patients with Metastatic Non-Small Cell Lung Cancer
Key statistics
On Monday, Immutep Ltd (IMMP:NMQ) closed at 1.90, 20.25% above the 52 week low of 1.58 set on Nov 21, 2023.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
Open | 1.91 |
---|---|
High | 1.95 |
Low | 1.87 |
Bid | 1.88 |
Offer | 1.93 |
Previous close | 1.94 |
Average volume | 978.29k |
---|---|
Shares outstanding | 145.26m |
Free float | 141.38m |
P/E (TTM) | -- |
Market cap | 288.52m USD |
EPS (TTM) | -0.2625 USD |
Data delayed at least 15 minutes, as of Jul 22 2024 21:00 BST.
More ▼